Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.18
-0.10 (-7.81%)
At close: May 09, 2025, 12:47 PM

Marker Therapeutics Revenue

Marker Therapeutics reported an annual revenue of $6.59M, reflecting a 99.06% growth. For the quarter ending December 31, 2024, Marker Therapeutics generated $2.25M in revenue.
Revenue (ttm)
$6.59M
Revenue Growth
99.06%
Price / Sales Ratio
4.24
Revenue / Employee
$1.32M
Employees
5
Market Cap
13.29M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.